Trial Profile

Comparative Study to Evaluate the Relative Bioavailability Between a Fixed-dose Combination Product of 90 mg Ticagrelor/100 mg Acetylsalicylic Acid vs Administration of the Reference Monotherapies in Healthy Subjects.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 13 Mar 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Aspirin (Primary) ; Aspirin/ticagrelor (Primary) ; Ticagrelor (Primary)
Indications Abdominal aortic aneurysm; Acute coronary syndromes; Cardiovascular disorders; Community-acquired pneumonia; Coronary artery disease; Stroke
Focus Pharmacokinetics
Sponsors Laboratorios Silanes

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com